“ResultsIn the adjusted mITT … treatment, patients treated with CS had a significant reduced … in the medial compartment ( celecoxib –8.1 % ± 4.2, CS –6.3 % ± 3.2; p = 0.018) and medial condyle (–7.….5 % ± 3.9; p = 0.008); no significant effect was seen in the lateral compartment.”
“…,CS reduced CVL … months ( celecoxib –5.6 % ± 3.0, CS –4.5 % ± 2.6; p = 0.049) and 24 months (celecoxib –8.4 % ± 4.2, CS –6.6 % ± …), and in the medial condyle at 24 months (celocoxib –8.1 % ± 4.7, CS –5.7 % ± 4.0; p = 0.010).”